Vyakaranam, A.R.; Crona, J.; Norlén, O.; Granberg, D.; Garske-Román, U.; Sandström, M.; Fröss-Baron, K.; Thiis-Evensen, E.; Hellman, P.; Sundin, A.
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE. Cancers 2019, 11, 909.
https://doi.org/10.3390/cancers11070909
AMA Style
Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A.
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE. Cancers. 2019; 11(7):909.
https://doi.org/10.3390/cancers11070909
Chicago/Turabian Style
Vyakaranam, Achyut Ram, Joakim Crona, Olov Norlén, Dan Granberg, Ulrike Garske-Román, Mattias Sandström, Katarzyna Fröss-Baron, Espen Thiis-Evensen, Per Hellman, and Anders Sundin.
2019. "Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE" Cancers 11, no. 7: 909.
https://doi.org/10.3390/cancers11070909
APA Style
Vyakaranam, A. R., Crona, J., Norlén, O., Granberg, D., Garske-Román, U., Sandström, M., Fröss-Baron, K., Thiis-Evensen, E., Hellman, P., & Sundin, A.
(2019). Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE. Cancers, 11(7), 909.
https://doi.org/10.3390/cancers11070909